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Eyebrow hairs from actinic keratosis patients
harbor the highest number of cutaneous human
papillomaviruses
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Abstract
Background: Cutaneous human papillomavirus (HPV) infections seem to be associated with the onset of actinic
keratosis (AK). This study compares the presence of cutaneous HPV types in eyebrow hairs to those in tissues of
normal skin and skin lesions of 75 immunocompetent AK patients.
Methods: Biopsies from AK lesions, normal skin and plucked eyebrow hairs were collected from each patient. DNA from
these specimens was tested for the presence of 28 cutaneous HPV (betaPV and gammaPV) by a PCR based method.
Results: The highest number of HPV prevalence was detected in 84% of the eyebrow hairs (63/75, median 6 types)
compared to 47% of AK lesions (35/75, median 3 types) (p< 0.001) and 37% of normal skin (28/75, median 4 types)
(p< 0.001), respectively. A total of 228 HPV infections were found in eyebrow hairs compared to only 92 HPV infections
in AK and 69 in normal skin. In all three specimens HPV20, HPV23 and/or HPV37 were the most prevalent types. The
highest number of multiple types of HPV positive specimens was found in 76% of the eyebrow hairs compared to 60%
in AK and 57% in normal skin. The concordance of at least one HPV type in virus positive specimens was 81%
(three specimens) and 88-93% of all three combinations with two specimens.
Conclusions: Thus, eyebrow hairs revealed the highest number of cutaneous HPV infections, are easy to collect and are
an appropriate screening tool in order to identify a possible association of HPV and AK.
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Background
Human papillomaviruses (HPV) are non-enveloped
double-stranded DNA viruses that infect epithelial cells.
Presently, 151 HPV types are completely characterized
(http://pave.niaid.nih.gov) and classified into mucosal/
genital (alphaPV) and cutaneous (betaPV, gammaPV,
muPV, and nuPV) HPV types, based on sequence ana-
lyses and clinical manifestation [1,2]. Their causal associ-
ation with (ano)genital carcinoma is fully established
[3,4]. The increased risk of cutaneous squamous cell car-
cinoma (SCC) in the presence of HPV infections of im-
munocompetent as well as immunosuppressed patients
enlarged the interest in the role of cutaneotropic HPV in
skin cancer [5-7]. Several studies showed oncogenic po-
tential of cutaneous HPV types with both in vitro (differ-
ent cell lines) and in vivo models (animals) [8-15]. The
molecular mechanisms of beta1PV (e.g., HPV5, HPV8,
and HPV20) are very likely different from beta2PV (e.g.
HPV23 and HPV38) [8,10,15]. At present, HPV38 is the
only cutaneous type, which is able to immortalize hu-
man primary keratinocytes [10] indicating that the onco-
genic potential of beta2PV seems to be higher compared
to the beta1PV types. However, to proof the causal role
of HPV and skin cancer, 4 major criteria have to be ful-
filled; i) and ii) presence and activity of HPV, iii)
transforming properties and iv) increased risk in epi-
demiological studies.
The first evidence for the association of HPV in the
development of actinic keratosis (AK) and cutaneous SCC
was shown in patients with the disease Epidermodysplasia
* Correspondence: ingo.nindl@charite.de
1Charité, Department of Dermatology, Venereology and Allergy, Skin Cancer
Center Charité, University Hospital of Berlin, Berlin, Germany
2DKFZ – Charité, Viral Skin Carcinogenesis Group, Division Viral
Transformation Mechanisms, German Cancer Research Center (DKFZ),
Heidelberg, Germany
Full list of author information is available at the end of the article
© 2013 Schneider et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Schneider et al. BMC Infectious Diseases 2013, 13:186
http://www.biomedcentral.com/1471-2334/13/186
verruciformis (EV) [16,17]. EV patients suffer a rare genetic
defect that results in the formation of macular lesions,
which frequently progress to SCC [18]. In the SCC lesions
of EV patients, cutaneous HPV types (predominantly
beta1PV types especially HPV5 and HPV8) have been
detected and are very likely etiologically linked with skin
cancer in this specific genetic background [19], which is
supported by HPV expression in skin tumors of EV pa-
tients [20].
In SCC of non-EV patients both beta1PV and beta2PV
were detected [7,21]. In large epidemiological studies
HPV23 was the most prevalent type in the normal popu-
lation as well as in immunosuppressed and immuno-
competent skin cancer patients [5,7,22]. However, in
contrast to genital HPV, no specific HPV type has been
associated with an increased risk of skin cancer. The es-
timated relative risk (odds ratio) of SCC increased with
the number of cutaneous HPV types and was highest in
biologically active infections (presence of both antibodies
and DNA for at least one HPV type) [5,7]. Moreover,
not all dysplastic cells are infected with cutaneous HPV
resulting in a low viral load. Only one of approximately
100–1,000 skin tumor cells are HPV infected with a
higher viral load in AK compared to SCC [23]. In sum-
mary, it is very likely that HPV types are a co-factor in
association with UV-radiation in the early pathogenesis
of cutaneous SCC [24-26].
So far, only little is known about the natural history of
cutaneous HPV types and in previous epidemiological
studies mostly eyebrow hairs, skin swabs and rarely nor-
mal skin samples have been used to determine the cuta-
neous HPV profile of patients or volunteers [27-29].
Cutaneous HPV types are present in hair follicles [27]
with a high concordance of different non-genital body
sites [30]. Hair follicles are very likely the natural reser-
voir of cutaneous HPV types and are easy to collect.
Therefore, they may be a useful noninvasive marker
of monitoring cutaneous HPV infections. However,
whether eyebrow hairs or normal skin should be used to
examine cutaneous HPV infections of AK patients is still
unknown. In our study, we analyzed cutaneotropic HPV
types in eyebrow hairs, normal skin and AK lesions to




This study was designed according to a previously
reported study analyzing the tumor-specific mutations of
p53, p16INK4a and Ha-Ras in immunocompetent AK pa-
tients [31]. Briefly, cryo-biopsies of 75 AK patients (aged
57–88 years old, median 71) were taken from the scalp
(sun-exposed, low-graded AK lesions) and the inner site
of the upper arm (sun-shielded, normal skin) at the
Charité in Berlin. Normal skin and AK lesions were
placed in liquid nitrogen within 2 min after resection
and stored at −70°C. We have performed frozen sections
of all divided AK lesions to confirm the presence of dys-
plastic cells before we have isolated the DNA. The other
half of each AK tumor biopsy was fixed in formalin and
embedded in paraffin for histological evaluation. More-
over, 8–10 eyebrow hairs were plucked from each AK
patient and stored at −70°C until processing. The study
was approved by the local ethics committee at the Charité,
University Hospital Berlin, Berlin, Germany (number Si.
248) and was conducted according to the Declaration of
Helsinki. All patients gave written consent.
Cutaneous HPV detection and genotyping
DNA isolation of both cryo-biopsies and eyebrow hairs
was performed using QIA-amp DNA Mini Kit (Qiagen;
Hilden Germany) according to the manufacturer’s proto-
col. The samples were eluted in 100 μl of AE buffer and
stored at −20°C until processing. HPV detection and
typing was performed as previously described [32,33].
With this consensus primer-mediated PCR method, we
were able to detect 25 beta and 3 gamma cutaneous
HPV types (BGC-PCR) amplifying a 72-bp L1 fragment.
Briefly, each PCR included three negative controls
(water), three positive controls containing 10, 100, or
1000 copies of HPV8 plasmid DNA in a background of
100ng human placental DNA per reaction and 10ng/μl
template DNA. Genotyping was performed with 28 HPV
specific 5-amino-linked oligonucleotides by reverse-line
-blotting (RLB). The quality of each clinical specimen
was examined by β-globin PCR, as described previously
[34], and only PCR positive specimens were included in
the present study. All clinical specimens were analyzed
twice on different days, and HPV types were only scored
if both experiments revealed consistent results. The re-
producibility of both experiments was very high and
similar as previously described [32].
Statistical analyses
The prevalence of cutaneous HPV in each specimen
(eyebrow hairs, biopsies of AK and normal skin) was cal-
culated. A specimen was rendered positive if at least one
HPV type was detected and statistical analysis was
performed using chi-square testing or fisher-exact test-
ing, when frequencies were smaller than five. A p-value
of < 0.05 was considered significant either for alpha, or
for alpha multiple with p-adjustment. HPV concordance
between any two sample types of the three different
specimens (eyebrow hairs, AK, and normal skin) was
calculated with the U-test by Wilcoxon, Mann, and
Whitney (Figure 1). Kappa-values express the proportion
of possible agreement beyond chance. A kappa estimate
of less than 0.4 represents poor agreement, a kappa
Schneider et al. BMC Infectious Diseases 2013, 13:186 Page 2 of 7
http://www.biomedcentral.com/1471-2334/13/186
estimate between 0.4 and 0.75 correlates fair to good
agreement, and a kappa estimate of more than 0.75 indi-
cates excellent agreement.
Results
HPV infections in three different specimens
A significant higher number of cutaneous HPV infec-
tions (betaPV and gammaPV) were detected in eyebrow
hairs (63/75; 84%) compared to AK lesions (35/75; 47%)
and normal skin (28/75; 37%) (p<0.001), respectively. All
28 HPV types examined were detected in the present
cohort (Additional file 1: Table S1). The following HPV
types were not detected in eyebrow hairs (HPV22), in
AK (HPV types 22, 49, 60, and 76), and in normal skin
(HPV types 19, 25, 38, 47, 49, 50, 60, 75, 76, and 92)
(Figure 2). Only HPV49, HPV60 and HPV76 were exclu-
sively found in eyebrow hairs, however with a low total
number of HPV types (1–3). Thus, no specific HPV type
seems to be associated with AK or the control group
(hairs and/or normal skin). The most prevalent HPV
types were HPV12, HPV15, HPV20, HPV23, and HPV37
in eyebrow hairs (at least 15/75), and HPV20 and
HPV37 in both AK and normal skin (at least 10/75)
(Figure 2). A high prevalence of HPV20 and HPV37 was
found in all three specimens, and thus these HPV types
were not AK specific. The presence of a single HPV type
was nearly two-fold higher in AK and normal skin (40%
and 43%) versus eyebrow hairs (24%) resulting in a high
number of multiplicity in eyebrow hairs (Figure 3). With
other words, multiple infections were found in 76% of
the eyebrow hairs, compared to a lower number of 60%
in AK and 57% in normal skin. From the HPV positive
specimens multiple infections with at least 5 HPV types
were present in 35% of eyebrow hairs (22/63) compared
to only 11% in both AK (4/35) and normal skin (3/28)
(Figure 3). In eyebrow hairs, up to 10 different HPV
types were present in a single specimen (median 6
types). In AK and normal skin up to 9 types were found
with a lower median number of HPV types (median 3
and 4 types, respectively). Overall, HPV prevalence, mul-
tiple infections and the number of different HPV types
present in a single specimen were highest in eyebrow
hairs compared to lower numbers in biopsies of AK
lesions and normal skin.
Concordance of HPV infections in eyebrow hairs, normal
skin and AK
We defined concordant infections with different strin-
gencies of at least one and up to six HPV types present
in two or three different specimens of one patient. In
this analysis only HPV positive specimens were included.
Overall cutaneous HPV agreement of at least one HPV
type was between 81-93% in all four combinations
of three samples (Figure 1). The highest number of con-
cordant infections with at least one HPV type was found
in eyebrow hairs compared to AK (91%, 32/35) or to
normal skin (93%, 26/28). A marginal lower number of
88% was observed in AK lesions compared to normal
skin. In eyebrow hairs, AK and normal skin 81% of the
specimens were infected with the same HPV of at least
one type. Using a more stringent definition of concord-
ance with the same HPV infection of at least two types,
Figure 1 Concordance of HPV infections. Concordant infections of HPV positive specimens with at least 1–6 cutaneous HPV types in eyebrow
hairs, actinic keratosis (AK), and normal skin are presented. The overall agreements of four combinations are shown with different definitions of
concordance. Specimens were classified as concordance if they contained the same HPV of at least one HPV type, two types et cetera. The
overall HPV agreement of at least one HPV type was 81-93%, and of at least two HPV types was 42-54% of all 4 combinations, respectively. The
kappa values calculated with all 75 specimens of at least one (≥1) and two (≥2) type(s) in common of hairs versus AK was 0.314 (95% CI:
0.167-0.460) and 0.321 (95% CI: 0.178-0.463) (fair agreement), hairs versus normal skin was 0.217 (95% CI: 0.099-0.335) and 0.259 (95% CI:
0.129-0.390) (fair agreement), and AK versus normal skin was 0.692 (95% CI: 0.527-0.856) and 0.621 (95% CI: 0.410-0.833) (good agreement).
No., numbers.
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the concordant infections decreased to 54% (hairs and
AK), 50% (hairs and normal skin), 46% (AK and normal
skin), and 42% (hairs, AK, and normal skin), respectively.
In a direct comparison of all 75 specimens, only fair
agreements were found between hairs versus AK or nor-
mal skin (kappa values of 0.314 or 0.217). The highest
kappa value of 0.692 (95% CI: 0.527-0.856) was esti-
mated in AK versus normal skin (Figure 1), which ex-
press a good agreement. The kappa values show the high
HPV concordance in biopsies (AK lesions and normal
skin), which differ in hairs due to the higher number of
HPV infections.
Discussion
Eyebrow hairs are infected with cutaneous HPV types,
they are easy to collect and often used in epidemio-
logical studies as noninvasive markers of HPV infections.
Alternatively, instead of eyebrow hairs perilesional tissue
or normal skin can be used as a control and reference of
skin cancer. Both specimens are difficult to collect, only
rarely used and normally not available especially in
large epidemiological studies. Currently it is unknown
whether normal skin tissue or eyebrow hairs best
represent the cutaneous HPV status of AK patients. In
our present comprehensive study, we evaluated the
Figure 2 Prevalence of cutaneous HPV types. HPV infections of all 28 examined cutaneous HPV types (beta-1, -2, -3, -4, -5, and gamma PV) in
three different specimens of 75 AK patients. The total of HPV infections was found highest in eyebrow hairs (228) compared to significantly lower
viral infections in AK (92) and in normal skin (69). No., numbers.
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prevalence and the concordant infections of cutaneous
HPV types in eyebrow hairs and normal skin compared
to skin lesions from 75 AK patients. We identified that
eyebrow hairs contained the highest number of different
HPV types.
The viral load of cutaneous HPV types in eyebrow
hairs, normal skin, AK and cutaneous SCC is normally
very low [23,35,36]. Only one of 100–1,000 cells are
infected with cutaneous HPV types but the number of
multiple infections is very high [26]. Thus, methods with
a high sensitivity and a large spectrum of types are
required to detect all cutaneous HPV types that are
present in humans.
Eyebrow hairs were collected from 126 AK patients,
and cutaneous HPV types were detected in 54% of hairs
by a type specific PCR method able to detect six HPV
types [37]. We found more cutaneous HPV types and a
higher number of multiple infections in hairs of AK pa-
tients. The difference is most likely due to the limited
number of HPV types detected compared to 28 types ex-
amined in our study. Eyebrow hairs of 171 participants
were examined to calculate the risk of betaPV infections of
AK [38]. Any betaPV type was detected in 73% of healthy
individuals, and in 70-72% of AK patients, which was simi-
lar with 84% in hairs of AK patients of our study.
De Koning and colleagues examined eyebrow hairs
from 845 healthy individuals (SCC-free) from six differ-
ent countries and cutaneous HPV infections were
detected in 84-91% [22]. Another study analyzed eye-
brow hairs of 845 healthy humans without SCC from
three countries and cutaneous HPV types were found in
89% [7]. Thus, the percentage of cutaneous HPV types
in eyebrow hairs of healthy individuals was high and
comparable with AK patients.
Only few studies examined cutaneous HPV types in
normal skin biopsies, because routinely only perilesional
skin is removed during surgery of skin cancer. A low
number of cutaneous HPV was found in 16% of normal
skin (57 skin biopsies) [21]. In a further study 72 normal
skin samples were collected and typed for cutaneous
HPV by a degenerated nested PCR technique and HPV
prevalence in these lesions was 18% [39]. In our study, a
higher prevalence of cutaneous HPV in normal skin was
found.
In a recent comparative study cutaneous HPV infec-
tions of 21 SCC patients were examined with four differ-
ent specimens; eyebrow hairs, perilesional skin, normal
skin and SCC [40]. A high overall HPV prevalence was
detected in every specimen (81% to 95%), and a signifi-
cantly higher median number of HPV types in SCC
(6 types), perilesional skin and eyebrow hairs (5 types)
compared to normal skin (2 types). In our study, we
observed a lower HPV prevalence in normal skin (37%
versus 81%) but a similar high prevalence in eyebrow
hairs. We have collected normal skin biopsies from the
inner site of the upper arm from 75 AK patients com-
pared to normal skin from the mirror image site of 21
SCC patients. Both PCR based methods detect the same
beta HPV types and have a comparable sensitivity, thus
the different methods used in both studies are very un-
likely responsible for the difference. Another explanation
is the different cohort (AK in our study versus SCC pa-
tients in the other study).
Cutaneous HPV infections were found in 41% of AK
(27 skin biopsies) by PCR based methods able to detect
approximately 100 HPV types [21]. We detected a simi-
lar number of cutaneous HPV types in skin lesions from
75 AK. In another study a higher prevalence of cutane-
ous HPV types (85%) was found in 54 AK lesions by a
nested PCR [41]. The different prevalence rates in skin
lesions (85% versus approximately 50%) may be due to a
higher sensitivity of nested PCR versus single PCR, the
Figure 3 Muliplicity of HPV infections. The percentages of single (1 type) and multiple infections (2–10 types) of HPV positive eyebrow hairs,
actinic keratosis (AK) and normal skin are shown. The highest number of multiple infections was observed in 76% of the eyebrow hairs
(48/63; median 6 types), compared to lower numbers of 60% in AK (21/35; median 3 types), and of 57% in normal skin (16/28; median 4
types), respectively.
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different cohorts or the low number of specimens exam-
ined. Further studies have to be performed to estimate
the accurate HPV prevalence in AK lesions.
Conclusions
In our study, not a specific type or particular combinations
of HPV types were detected in AK lesions compared to
normal skin and eyebrow hairs. The concordance of all
three different specimens of HPV positive samples was
high. Most importantly, we identified a significant higher
number of cutaneous HPV types in eyebrow hairs com-
pared to normal skin and skin lesions of AK patients. Thus,
eyebrow hairs seem to be an appropriate marker to exam-
ine the role of cutaneous HPV and AK.
Additional file
Additional file 1: Table S1. Cutaneous HPV types detected in 3
different specimens of 75 immunocompetent AK patients.
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